Design and evaluation of nanostructured lipid carriers loaded with <i>Salvia officinalis</i> extract for Alzheimer's disease treatment-Reference-Cited by-同舟云学术

Design and evaluation of nanostructured lipid carriers loaded with Salvia officinalis extract for Alzheimer's disease treatment

Published:2022-01-12 Issue:6 Volume:110 Page:1368-1390
ISSN:1552-4973
Container-title:Journal of Biomedical Materials Research Part B: Applied Biomaterials
language:en
Short-container-title:J Biomed Mater Res

Author:

Markova Elena¹,Taneska Lea¹,Kostovska Monika¹,Shalabalija Dushko¹,Mihailova Ljubica¹,Glavas Dodov Marija¹,Makreski Petre²,Geskovski Nikola¹,Petrushevska Marija³,N. Taravari Arben⁴,Simonoska Crcarevska Maja¹^ORCID

Affiliation:

1. Institute of Pharmaceutical Technology, Center of Pharmaceutical Nanotechnology, Faculty of Pharmacy Ss. Cyril and Methodius University in Skopje Skopje North Macedonia

2. Institute of Chemistry, Faculty of Natural Sciences and Mathematics Ss. Cyril and Methodius University in Skopje Skopje North Macedonia

3. Institute of Pharmacology, Faculty of Medicine Ss. Cyril and Methodius University in Skopje Skopje North Macedonia

4. University Clinic for Neurology, Faculty of Medicine Ss. Cyril and Methodius University in Skopje Skopje North Macedonia

Publisher

Wiley

Subject

Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm.b.35006

Reference99 articles.

1. First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease

2. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior

3. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

4. Review: Therapy for Alzheimer's disease: how effective are current treatments?

5. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructured Lipid Carriers for oral treatment of leishmaniasis: Design and preclinical evaluation;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-08

2. Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects;Ageing Research Reviews;2024-07

3. QbD-based optimization and evaluation of chitosan-adorned nanostructured lipid carriers for nose-to-brain delivery of 17β-Estradiol in rat model of Alzheimer's disease;Journal of Drug Delivery Science and Technology;2024-06

4. Lipid nanoparticles in targeting Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

5. Current strategies of detecting Aβ species and inhibiting Aβ aggregation: Status and prospects;Coordination Chemistry Reviews;2023-11